Howard Hughes Medical Institute’s Kite Pharma, Inc. KITE Stock Holding History

Howard Hughes Medical Institute’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-893	Closed	-$40K	–	179
2016 Q4	$40K	Sell	893 -2,807	-76%	-$138K	0.01%	142
2016 Q3	$207K	Buy	3,700 +269	+8%	+$15K	0.05%	126
2016 Q2	$172K	Buy	3,431 +348	+11%	+$17.1K	0.06%	122
2016 Q1	$142K	Sell	3,083 -161	-5%	-$7.8K	0.03%	124
2015 Q4	$200K	Buy	3,244 +2,369	+271%	+$167K	0.03%	130
2015 Q3	$49K	Buy	+875	New	+$55K	0.01%	146
2015 Q1	–	Sell	-202	Closed	-$12K	–	200
2014 Q4	$12K	Buy	+202	New	+$8.51K	﹤0.01%	163

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Howard Hughes Medical Institute's KITE Position: Q1 2017 in Review

Howard Hughes Medical Institute sold out of Kite Pharma, Inc. (KITE) in Q1 2017, closing a stake of 893 shares — an estimated $40K sold.

Howard Hughes Medical Institute first reported a position in KITE in Q4 2014 and held it in 7 quarters. The position peaked at $207K in Q3 2016. 209 funds tracked by Wall St. Rank hold KITE as of Q1 2017.

Howard Hughes Medical Institute reported no remaining Kite Pharma, Inc. position as of Q1 2017 after selling out during the quarter.
Howard Hughes Medical Institute sold 893 Kite Pharma, Inc. shares in Q1 2017, an estimated $40K.
Howard Hughes Medical Institute first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 7 quarters.
Howard Hughes Medical Institute's Kite Pharma, Inc. position peaked at $207K in Q3 2016.
209 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2017, filed 25 Apr 2017.